Cancer (Tumor) Profiling Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Cancer (Tumor) Profiling Market size is projected to reach USD 13.9 billion by 2028 from USD 8.3 billion in 2020, at a CAGR of 10% during the forecast period 2022-2028. 

Cancer/tumor profiling provides information about the genes that cause cancer, providing useful insights related to cancer mechanisms. The potential of cancer profiling is not limited to common cancers such as lymphoma and breast cancer, but is also useful for molecular profiling of lung cancer, prostate cancer and acute leukemia. Cancer profiling plays an important role in diagnosis at the molecular level. Because a better understanding of cancer tumors helps doctors make appropriate treatment decisions and avoid “overtreatment” of cancer patients.

 


Market Segments

By Technology

  • Next-generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • In Situ Hybridization (ISH)
  • Microarray
  • Others

By Technique

  • Genomics
  • Proteomics
  • Epigenetics
  • Metabolomics

Key Players

Some of the major key players operating in the global cancer profiling market include Proteome Sciences PLC, Life Technologies Corporation, Illumina, Inc., BioTheranostics, RiboMed Biotechnologies Inc., NeoGenomics Laboratories, Oxford Gene Technology Ltd., Genomic Health Inc., Agendia, and Oncopath Laboratories.


Scope of the Report

The research study analyzes the global Cancer (Tumor) Profiling industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Cancer (Tumor) Profiling Market Report

1. What was the Cancer (Tumor) Profiling Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Cancer (Tumor) Profiling Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Cancer (Tumor) Profiling Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report will be delivered within 48-72 hours after payment confirmation